Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Charlie Hoban

Partner, Health & Life Sciences, Oliver Wyman

Part 2: Unexpected Players are Rethinking Healthcare

Healthcare’s largest inflection point in many years is upon us. Now, health systems must rise to the challenge.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Part 1: Reassessing Physical Needs in a Virtual World

There's a market gap for a new care delivery entity to emerge.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A critical cybersecurity and ransomware to-do list for leaders.

Partner, Digital and Financial Services, Cyber Platform Lead, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Even the most fruitful innovators have seen small impact thus far. It’s time to hold the industry to a quantifiable yardstick.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Insights in your inbox

Subscribe

Here's What Blockchain is, and What it Isn't

Blockchain may not be an urgent operational focus, but it's still absolutely worth exploring.

CIO, Beth Israel Deaconess Healthcare System, International Healthcare Innovation Professor, Harvard Medical School
Partner, Health & Life Sciences, Oliver Wyman

As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

In this episode of the Oliver Wyman Health Podcast, we talk what's next for artificial intelligence, machine learning, IoT, and blockchain.

CIO, Beth Israel Deaconess Healthcare System, International Healthcare Innovation Professor, Harvard Medical School
Partner, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Partner, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe